The North American DNA Vaccine market is anticipated to grow at a CAGR 42.8% during the forecast period. North America is creating a significant opportunity for the DNA vaccination market. Several types of research have been conducted by medical research centers in the region. For instance, In Dec 2017, the National Institute of Allergy and Infectious Diseases (NIAID), a part of NIH (National Institute of Health) has developed a Gene-based Zika vaccine. The center developed two different plasmids for clinical testing, including VRC5283 and VRC5288. In clinical trials, it was found that vaccinations are safe; however, some participants experienced swelling, redness and inflammation at the injection site.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-dna-vaccines-market
Moreover, increasing funding for activities for DNA vaccinations is also primarily driving the DNA vaccination market in North America. As an instance, In Jan 2018, Bill and Melinda Gates Foundation have granted $1.4 million to the Wistar Institute (Philadelphia) to develop a synthetic DNA-based vaccine for malaria.
Further, the North American market is analyzed on the basis of the countries that are contributing significantly towards the growth of the market. The North American market is further bifurcated into the United States and Canada. North American DNA vaccine is further segmented into type, technology and application. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery. Based on application, the market is segmented into oncology, infectious disease and others.
The key market player that are active in the market includes Arbutus Biopharma Corp., Dendreon Pharmaceuticals LLC, GE Healthcare, GlaxoSmithKline PLC., Green Cross Corp., Innovio Biomedical Corp., Immunomic Therapeutics, Merck & Co., Pfizer Inc., Protein Sciences Corp., Qed Biosciences Inc., Sanofi Inc., Tolerion Inc., Vical Inc. and Zoetis Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
North American DNA Vaccine Market Segmentation
By Type
- Animal DNA Vaccine
- Human DNA Vaccine
By Technology
- Plasmid DNA Vaccine
- Plasmid DNA Delivery
By Application
- Oncology
- Infectious Disease
- Others
A full report of North American DNA Vaccine Market available @ https://www.omrglobal.com/industry-reports/north-american-dna-vaccines-market
North American DNA Vaccine Market Regional Analysis
- United States
- Canada
